PHR Stock Analysis: Buy, Sell, or Hold?
PHR - Phreesia, Inc.
$11.22
0.24 (2.19%)
ā²
5d:
-4.92%
30d:
-9.0%
90d:
-34.08%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Mar 30, 2026
0d
Get Alerted When PHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
ā BUY SIGNAL: PHR trading at deep discount. Market pricing in -16.0% annual earnings decline, creating value opportunity for patient investors.
ā BUY SIGNAL: PHR trading at deep discount. Market pricing in -16.0% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.96
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.33
49.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PHR is currently trading at $11.22, which is considered slightly low relative to its 30-day fair value range of $11.22 to $12.28. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.3) compared to its historical average (12.3). Remarkably, the market is currently pricing in an annual earnings decline of 16.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, PHR is in a strong downtrend. The price is currently testing key support at $10.89. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $27.89 (+154.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PHR is in a strong downtrend. The price is currently testing key support at $10.89. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $27.89 (+154.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$11.22 -
$12.28
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 154.1% below Wall St target ($27.89)
Fair Price Analysis
30-Day Fair Range
$11.22 -
$12.28
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$10.89
Resistance Level
$12.36
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.31
Wall Street Target
$27.89
(+154.1%)
Revenue Growth (YoY)
45.7%
Profit Margin
-1.2%
Valuation Discount vs History
-16.0% cheaper
PE vs Historical
7.3 vs 12.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.0%
(market-implied from PE analysis)
1-Year Target
$9.88
(-10%)
2-Year Target
$8.89
(-19%)
3-Year Target
$8.00
(-27%)
3-Yr Target (if PE normalizes)
(PE: 7ā12)
$13.46
(+23%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 28.8%)
$71.78
(+554%)
Base:
(SPY PE: 7.3, Growth: 28.8%)
$23.44
(+114%)
Bear:
(PE: 6.2, Growth: 28.8%)
$19.92
(+81%)
š”
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.3 to 12.3
Stabilization Target:
$18.47
(+68.2%)
PE Expansion Potential:
+68.2%
Share & Embed Analysis
Last updated: March 30, 2026 1:34 PM ET
Data refreshes hourly during market hours. Next update: 2:34 PM
Data refreshes hourly during market hours. Next update: 2:34 PM
š„ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Amy Beth Vanduyn
SELL
2202 shares
2026-01-16
Balaji Gandhi
SELL
4687 shares
2026-01-16
David Linetsky
SELL
6038 shares
2026-01-16
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 50 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 46 HOLD |
|
GEHC
GE HealthCare Technologiā¦ |
STRONG BUY
21 analysts |
$90 | 58 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 60 BUY |
|
WAY
Waystar Holding Corp. Coā¦ |
STRONG BUY
13 analysts |
$37 | 55 HOLD |
